ARMYDA 600*2 - Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 600*2
Project Objectives
A randomized study comparing a single 600 mg clopidogrel loading dose versus 600 mg in two doses, which are 12 hours apart, in patients undergoing percutaneous coronary revascularization.
Start/End Dates
February 2012 - ongoing
Principal Investigator
- Dr. Giuseppe Patti - Local Principal Investigator
- Prof. Germano Di Sciascio
Host Institution
Campus Bio-Medico University of Rome